Concepedia

Xiomara Fernandez

XF

Statistics

Publications

30

Citations

1.7K

H-Index

20

Active since

1979

Affiliations

AGCO (United Kingdom)(Current)

ENT and Allergy

University of Florida

Institute of Neurobiology

Merck & Co., Inc., Rahway, NJ, USA (United States)

Xiomara Fernandez is an author at AGCO (United Kingdom) specializing in medicine, pharmacology, and inflammatory lung disease.

Top concepts

MedicinePharmacologyImmunologyInflammatory Lung DiseaseDrug DiscoveryLung InflammationAsthmaAllergyInflammationAutoimmunity

Publications per year

1979–2013

30

Publications

30

Effects of an antibody to interleukin-5 in a monkey model of asthma.

Peter Mauser, Aileen Pitman, Xiomara Fernandez et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 324 citations

Asthma, Inflammatory Lung Disease, Lung Inflammation +17

Inhibitory Effect of the TRFK-5 Anti-IL-5 Antibody in a Guinea Pig Model of Asthma

Peter Mauser, Aileen Pitman, Angela Witt et al. · American Review of Respiratory Disease · 1993 · 223 citations

Asthma, Inflammatory Lung Disease, Immunology +16

Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery

Thejani E. Rajapaksa, Mary Stover-Hamer, Xiomara Fernandez et al. · Journal of Controlled Release · 2009 · 135 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +11

Interleukin-5 Modulates Eosinophil Accumulation in Allergic Guinea Pig Lung

A. Gulbenkian, Robert W. Egan, Xiomara Fernandez et al. · American Review of Respiratory Disease · 1992 · 135 citations

Asthma, Allergy, Inflammatory Lung Disease +12

Effect of Sch 55700, a Humanized Monoclonal Antibody to Human Interleukin-5, on Eosinophilic Responses and Bronchial Hyperreactivity

Robert W. Egan, D. S. Athwal, Mark Bodmer et al. · Arzneimittelforschung · 2011 · 112 citations

Pulmonary Eosinophilia, Inflammatory Lung Disease, Immunology +16

Rows per page

1–5 of 30